Cardiology
Conditions
Abdominal Aortic Aneurysm
Angina (Angina Pectoris)
Aortic Aneurysm
Aortic Dissection
Aortic Regurgitation
Aortic Stenosis
Arrhythmia
Arrhythmogenic Cardiomyopathy
Atherosclerosis
Atrial Fibrillation
Atrial Flutter
Brugada Syndrome
Cardiac Amyloidosis
Cardiac Sarcoidosis
Cardiac Tamponade
Cardiomyopathy
Cardiovascular Disease
Carotid Artery Stenosis
Cholesterol Management
Coarctation of the Aorta
Commotio Cordis
Constrictive Pericarditis
Coronary Artery Disease
Dilated Cardiomyopathy
Ebstein's Anomaly
Endocarditis
Familial Hypercholesterolemia
Heart Attack (Myocardial Infarction)
Heart Block
Heart Failure
HFpEF (Heart Failure with Preserved Ejection Fraction)
Hypertension
Hypertrophic Cardiomyopathy
Infective Endocarditis
Left Ventricular Non-Compaction Cardiomyopathy
Loeys-Dietz Syndrome
Long QT Syndrome
Mitral Regurgitation
Mitral Stenosis
Myocarditis
Patent Foramen Ovale (PFO)
Pericarditis
Peripartum Cardiomyopathy
Peripheral Arterial Disease
Peripheral Artery Disease
Postural Orthostatic Tachycardia Syndrome (POTS)
Raynaud's Phenomenon
Stroke
Sudden Cardiac Death
Supraventricular Tachycardia
Takotsubo Syndrome
Thromboangiitis Obliterans (Buerger's Disease)
Valvular Heart Disease
Varicose Veins
Ventricular Fibrillation
Ventricular Tachycardia
Wolff-Parkinson-White Syndrome
Cardiology focuses on diseases and disorders of the heart and blood vessels, including structural, electrical, and vascular conditions.
Key Research Papers
Foundational and recent peer-reviewed publications across the major cardiology subspecialties — lipid management, hypertension, atrial fibrillation, heart failure, valvular disease, and acute coronary syndromes. Each citation links to the full text via DOI.
- Scandinavian Simvastatin Survival Study Group. Randomised Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease (4S). Lancet. 1994;344(8934):1383–1389. — doi:10.1016/S0140-6736(94)90566-5
- Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes (PROVE IT–TIMI 22). New England Journal of Medicine. 2004;350(15):1495–1504. — doi:10.1056/NEJMoa040583
- Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (FOURIER). New England Journal of Medicine. 2017;376(18):1713–1722. — doi:10.1056/NEJMoa1615664
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology. 2019;73(24):e285–e350. — doi:10.1016/j.jacc.2018.11.003
- Heart Outcomes Prevention Evaluation Study Investigators. Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients (HOPE). New England Journal of Medicine. 2000;342(3):145–153. — doi:10.1056/NEJM200001203420301
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. 2018;71(19):e127–e248. — doi:10.1016/j.jacc.2017.11.006
- Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation (CHA₂DS₂-VASc). Chest. 2010;137(2):263–272. — doi:10.1378/chest.09-1584
- Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation (RE-LY). New England Journal of Medicine. 2009;361(12):1139–1151. — doi:10.1056/NEJMoa0905561
- Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (ROCKET AF). New England Journal of Medicine. 2011;365(10):883–891. — doi:10.1056/NEJMoa1009638
- Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation (ARISTOTLE). New England Journal of Medicine. 2011;365(11):981–992. — doi:10.1056/NEJMoa1107039
- McMurray JJ, Packer M, Desai AS, et al. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure (PARADIGM-HF). New England Journal of Medicine. 2014;371(11):993–1004. — doi:10.1056/NEJMoa1409077
- McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF). New England Journal of Medicine. 2019;381(21):1995–2008. — doi:10.1056/NEJMoa1911303
- Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction (EMPEROR-Preserved). New England Journal of Medicine. 2021;385(16):1451–1461. — doi:10.1056/NEJMoa2107038
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients (PARTNER 3). New England Journal of Medicine. 2019;380(18):1695–1705. — doi:10.1056/NEJMoa1814052
- Maron DJ, Hochman JS, Reynolds HR, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease (ISCHEMIA). New England Journal of Medicine. 2020;382(15):1395–1407. — doi:10.1056/NEJMoa1915922
- The GUSTO Investigators. An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction (GUSTO-1). New England Journal of Medicine. 1993;329(10):673–682. — doi:10.1056/NEJM199309023291001
PubMed Topic Searches
Live PubMed queries that update as new papers are indexed.
- PubMed: coronary artery disease management
- PubMed: atrial fibrillation anticoagulation
- PubMed: HFrEF
- PubMed: HFpEF
- PubMed: hypertension guidelines
- PubMed: valvular disease & TAVR
- PubMed: cardiomyopathy
- PubMed: stroke prevention
- PubMed: peripheral artery disease
- PubMed: infective endocarditis
- PubMed: myocarditis
- PubMed: aortic aneurysm
All Cardiology Articles A–Z
Every article in this specialty, listed alphabetically.
- Abdominal Aortic Aneurysm
- Angina (Angina Pectoris)
- Aortic Aneurysm
- Aortic Dissection
- Aortic Regurgitation
- Aortic Stenosis
- Arrhythmia
- Arrhythmogenic Cardiomyopathy
- Atherosclerosis
- Atrial Fibrillation
- Atrial Flutter
- Brugada Syndrome
- Cardiac Amyloidosis
- Cardiac Sarcoidosis
- Cardiac Tamponade
- Cardiomyopathy
- Cardiovascular Disease
- Carotid Artery Stenosis
- Cholesterol Management
- Coarctation of the Aorta
- Commotio Cordis
- Constrictive Pericarditis
- Coronary Artery Disease (CAD)
- Dilated Cardiomyopathy
- Ebstein's Anomaly
- Endocarditis
- Familial Hypercholesterolemia
- Heart Attack (Myocardial Infarction)
- Heart Block
- Heart Failure
- HFpEF β Heart Failure with Preserved Ejection Fraction
- Hypertension
- Hypertrophic Cardiomyopathy
- Infective Endocarditis
- Left Ventricular Non-Compaction Cardiomyopathy
- Loeys-Dietz Syndrome
- Long QT Syndrome
- Mitral Regurgitation
- Mitral Stenosis
- Myocarditis
- Patent Foramen Ovale (PFO)
- Pericarditis
- Peripartum Cardiomyopathy
- Peripheral Arterial Disease
- Peripheral Artery Disease
- Postural Orthostatic Tachycardia Syndrome (POTS)
- Raynaud's Phenomenon
- Restrictive Cardiomyopathy
- Stroke
- Sudden Cardiac Death
- Supraventricular Tachycardia
- Takotsubo Syndrome
- Thromboangiitis Obliterans (Buerger's Disease)
- Valvular Heart Disease
- Varicose Veins
- Ventricular Fibrillation
- Ventricular Tachycardia
- Wolff-Parkinson-White Syndrome
Featured Videos
Connections
- Willem Einthoven — the ECG — what the tracing actually measures, and what it cannot tell you
- Forssmann, Cournand & Richards — cardiac catheterisation, which Forssmann first performed on himself and was sacked for
- Furchgott, Ignarro & Murad — nitric oxide — why nitroglycerin relieves angina, and where the supplement claims outrun it
- Goldstein & Brown — the LDL receptor, and the discovery that made statins possible
- Black, Elion & Hitchings — beta-blockers, and why they are not stopped abruptly
- Herbs covered on this site that discuss conditions in this specialty: Hibiscus · Epimedium (Horny Goat Weed) · Motherwort · Sida cordifolia (Bala) · Coleus forskohlii (Forskolin) · Olive Leaf (Olea europaea)
- Coronary Calcium Score (CAC)